Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

 

following the withdrawal of such registration statement on Form S-1 in connection with any abandonment of the IPO and (ii) the closing of the IPO.

 

Right of First Refusal and Co-Sale Agreement” means the agreement among the Company, the Purchasers, and certain other stockholders of the Company, dated as of the Initial Tranche Closing, in the form of Exhibit F attached to this Agreement.

 

Second Tranche Closing” shall have the meaning set forth in Section 1.2(b)(i) hereof.

 

Second Tranche Closing Notice” shall have the meaning set forth in Section 1.1(c)(ii) hereof.

 

Second Tranche Individual Purchase Exercise Notice” shall have the meaning set forth in Section 2.1(a)(i) hereto.

 

Second Tranche Individual Purchase Right” shall have the meaning set forth in Section 2.1(a)(i) hereto.

 

Second Tranche Individual Purchase Shares” shall have the meaning set forth in Section 2.1(a)(i) hereto.

 

Second Tranche Shares” shall have the meaning set forth in Section 1.1(c)(i) hereof.

 

Section 2.1(a) Closing” shall have the meaning set forth in Section 2.2(a)(i) hereto.

 

Section 2.1(b) Closing” shall have the meaning set forth in Section 2.2(b)(i) hereto.

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Series A Preferred Stock” means the Company’s Series A Preferred Stock, par value $0.001 per share.

 

Series A-1 Preferred Stock” means the Company’s Series A-1 Preferred Stock, par value $0.001 per share.

 

Series B Preferred Stock” means the Company’s Series B Preferred Stock, par value $0.001 per share.

 

Series C Preferred Stock” means the Company’s Series C Preferred Stock, par value $0.001 per share.

 

Series D Preferred Stock” shall have the meaning set forth in Section 1.1(b) hereof.

 

14